FIELD: medicine. SUBSTANCE: the present innovation deals with pharmacological compositions indicated for prophylaxis and treatment of stress and viral diseases and those associated with decreased immunity. The suggested composition of peptide delta of sleep, (DSIP)-reaferon, at the ratio of components in composition being 1•103-104 IU/1 mg DSIP-reaferon, provides antiviral action upon the body along with antistress effect and increases immunity, as well. As for DSIP-reaferon composition and those upon its basis at additional supplementation of glycine, carnosine, melatonin have the opportunity to increase body immunity, activate cerebral processes, favors prophylaxis and treatment of psychoemotional disorders and viral diseases. The suggested innovation enables to achieve synergistic effect of components applied to prevent the development of viral diseases at the background of stress and increase body immunity. EFFECT: higher efficiency of prophylaxis and therapy. 3 cl, 11 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR ARRESTING BY-SIDE EFFECTS ARISING AT COMPLEX AND COMBINED TREATMENT OF MALIGNANT NEOPLASM, TREATMENT OF VIRAL HEPATITIS AND INDUCED WITH ANTITUMOR AND OTHER CHEMIOPREPARATIONS AT SIMULTANEOUS PARANEOPLASTIC SYNDROME RELIEF | 1995 |
|
RU2084238C1 |
METHOD OF PREVENTION OF CHRONIC VIRAL HEPATITIS TYPE C RECURRENT AFTER VIRUS REMISSION | 2007 |
|
RU2348412C1 |
METHOD OF TREATMENT OF CHRONIC VIRAL HEPATITIS TYPE C | 2006 |
|
RU2345787C2 |
METHOD OF CORRECTING FAILURES IN REPRODUCTIVE ORGANS CAUSED BY HIGH TEMPERATURE | 2009 |
|
RU2418586C2 |
METHOD OF TREATING CHRONIC VIRAL HEPATITIS C WITH MEDICATIONS IN LIPOSOMAL FORM | 2011 |
|
RU2475263C1 |
METHOD OF TREATING TICK-BORNE ENCEPHALITIS | 2011 |
|
RU2473364C2 |
METHOD OF ACTIVATION OF A LIQUID, A DEVICE FOR ITS REALIZATION CONTAINING A MAGNETIC-RESONANCE ACTIVATOR AND THE MAGNETIC-RESONANCE ACTIVATOR | 2001 |
|
RU2244688C2 |
METHOD FOR CARRYING OUT INTERFERON THERAPY | 1995 |
|
RU2105566C1 |
METHOD OF TREATING ACUTE VIRAL HEPATITIS B AND MIXED HEPATITIS (B + C, B + D, B + C + D) | 2010 |
|
RU2446798C2 |
CYTOKINE-CONTAINING COMPOSITION FOR TREATING VIRAL DISEASES | 2009 |
|
RU2447897C2 |
Authors
Dates
2003-09-10—Published
2001-06-08—Filed